Expand LYCA Menu
LYCA MENU

Lycia Therapeutics (LYCA) closed at $31.77 on November 19, 2026, up 1.3% from the previous close, on volume of 273,790 shares (30-day average 432,589).

Key numbers
  • Last close: $31.77 (November 19, 2026)
  • 52-week range: $22.19 to $36.49
  • Market value: $1.7 billion

Data as of November 19, 2026.

LYCA Stock Summary and Trading Ideas (Lycia Therapeutics | NASDAQ:LYCA)

Lycia Therapeutics (LYCA) Frequently Asked Questions

What does Lycia Therapeutics do?

Lycia Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases.

What symbol and exchange does Lycia Therapeutics shares trade?

Lycia Therapeutics trades on the NASDAQ stock market under the symbol LYCA.

What is Lycia Therapeutics stock price doing today?

As of November 19, 2026, LYCA stock price climbed to $31.77 with 273,790 million shares trading.

How much is Lycia Therapeutics worth?

LYCA has a market cap of $1.66 billion. This is considered a Small Cap stock.

What are the top ETFs holding Lycia Therapeutics?

The top ETF exchange traded funds that LYCA belongs to (by Net Assets): VTI, VXF.

What are the support and resistance levels for Lycia Therapeutics (LYCA)?

LYCA support price is $29.13 and resistance is $33.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LYCA shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes